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Objectives. We examined the relationship among viability as-
sessment by dobutamine echocardiography (DE), positron emis-
sion tomography (PET) and thallium-201 single-photon emission
computed tomography (Tl-SPECT) to the degree of fibrosis.
Background. DE, PET and Tl-SPECT have been shown to be
sensitive in identifying viability of asynergic myocardium. How-
ever, PET and Tl-SPECT indicated viability in a significant
percentage of segments without dobutamine response or func-
tional improvement after revascularization.
Methods. Twelve patients with coronary artery disease and
severely reduced left ventricular function (EF 14.5 6 5.2%) were
studied with DE prior to cardiac transplantation: 5 had additional
PET and 7 had Tl-SPECT studies. Results of the three techniques
were compared to histologic findings of the explanted hearts.
Results. Segments with >75% viable myocytes by histology were
determined to be viable in 78%, 89% and 87% by DE, PET and
Tl-SPECT; those with 50–75% viable myocytes in 71%, 50% and
87%, respectively. Segments with 25–50% viable myocytes showed
response to dobutamine in only 15%, but were viable in 60% by
PET and 82% by Tl-SPECT. Segments with <25% viable myocytes
responded to dobutamine in 19%; however, PET and Tl-SPECT
demonstrated viability in 33% and 38%, respectively. Discrepant
segments without dobutamine response but viability by PET and
SPECT had significantly more viable myocytes by pathology than
did those classified in agreement to be nonviable but had signif-
icantly less viable myocytes than those classified in agreement to
be viable (p < .001).
Conclusions. These findings suggest that contractile reserve as
evidenced by a positive dobutamine response requires at least 50%
viable myocytes in a given segment whereas scintigraphic methods
also identify segments with less viable myocytes. Thus, the meth-
ods may provide complementary information: Nuclear techniques
appear to be highly sensitive for the detection of myocardial
viability, and negative tests make it highly unlikely that a signif-
icant number of viable myocytes are present in a given segment.
Conversely, dobutamine echo may be particularly useful for
predicting recovery of systolic function after revascularization.
(J Am Coll Cardiol 1998;32:1701–8)
©1998 by the American College of Cardiology
Assessment of myocardial viability is of critical importance for
the management of patients with chronic coronary artery
disease and reduced left ventricular function. Asynergic but
viable myocardium has been assumed to improve its systolic
function after revascularization, whereas nonviable segments
do not. Thus, patients with a large portion of dysfunctional but
viable myocardium are believed to benefit from revasculariza-
tion, whereas only transplantation can be offered to those with
few remaining viable segments (1–3). In addition, revascular-
ization of viable myocardium may be beneficial by preventing
remodeling and electrical instability.
Several techniques such as dobutamine echocardiography
(DE) (4–7), positron emission tomography (PET) (8,9) and
Tl-201 single-photon emission computed tomography (Tl-
SPECT) using a stress-redistribution-reinjection protocol (10)
or a rest-redistribution protocol (11,12) have been proposed
for the assessment of myocardial viability. Several studies that
compared these tests to each other and to wall-motion analysis
after bypass surgery have been reported: Sensitivity for detec-
tion of viability in asynergic segments was found to be accept-
able for all three techniques, although some studies reported
DE to be slightly less sensitive (13–19). However, most studies
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show that a high percentage of segments unresponsive to
dobutamine or without improvement of wall motion after
revascularization are still viable by PET or Tl-SPECT
(13,17,19,20–25). Furthermore, it has recently been shown that
the dobutamine response of dyssynergic myocardium is directly
related to the degree of thallium uptake (19,23,26).
Thus, we hypothesized that a positive dobutamine response
may require a higher percentage of viable myocytes in a given
segment than does the demonstration of perfusion and/or
metabolism by PET or Tl-SPECT. To address this hypothesis,
we studied patients prior to heart transplantation with DE,
PET and Tl-SPECT and compared the results with the his-
topathologic findings in the explanted hearts.
Methods
Study population. The study population consisted of 12
patients (all male; mean age 52 6 9 years) with severe left
ventricular dysfunction due to ischemic cardiomyopathy (mean
ejection fraction [EF] 14.5 6 5.2%) who ultimately underwent
transplantation. All patients had a history of myocardial in-
farction (anterior 12, inferior 10; none within 3 months of
transplantation) and all had severe multivessel disease on
coronary angiography. Each patient gave written informed
consent to participate in the study.
Echocardiography. Echocardiography was performed in all
patients using either a Vingmed 800 (Vingmed Sound, Horton,
Norway) with a 3.5-MHz transducer or a HP 1500 (Hewlett-
Packard Imaging Systems, Andover, MA). In addition to a
standard M-Mode, 2-D and Doppler echocardiographic study,
parasternal long axis and short axis views (level of the papillary
muscles) and apical two- and four-chamber views were re-
corded at baseline and at each stage of the dobutamine
protocol. Five and 10 mg/kg/min were administered for at least
5 min before imaging. The dosage was increased in 5-mg
increments each for 3 min. Dobutamine was discontinued
before the target dosage of 40 mg/kg/min was reached when
one of the following criteria occurred: systolic blood pressure
$240 mm Hg; diastolic blood pressure $120 mm Hg; severe
hypotension (systolic blood pressure ,90 mm Hg); significant
arrhythmias, signs of ischemia (worsening of regional wall
motion, angina), or severe patient discomfort.
Digitized cycles of each view were stored for later side-by-
side display in a quadscreen format to facilitate the comparison
of images at rest and during different rates of dobutamine
infusion. Images were also recorded on videotape.
Echocardiograms were read by investigators unaware of the
clinical, angiographic and scintigraphic findings in each pa-
tient. The standard 16-segment model was used for semiquan-
titative wall-motion analysis. Wall motion was described as
normal, mildly hypokinetic, severely hypokinetic, akinetic or
dyskinetic.
Segments were judged to be viable when wall motion was
normal or mildly hypokinetic at rest or when wall motion in
severely hypokinetic or akinetic segments improved by at least
one grade after dobutamine administration.
PET imaging. Positron emission tomography (PET) scan-
ning was performed in a nonselected subgroup of five patients
(PET was unavailable in the remaining patients for logistic
reasons). The PET imaging was performed using N-13 ammo-
nia and F-18 deoxyglucose (FDG) as tracers of regional
myocardial blood flow and glucose utilization. After an over-
night fast, patients were positioned in the PET scanner with a
Velcro strap fastened across their chest to minimize motion. A
20-min transmission scan was obtained first to correct emission
images for photon attenuation. Then, 10–15 mCi of N-13
ammonia were injected as a bolus, and 5 min later a 20-min
image was acquired. After physical decay of N-13 (40 min),
10 mCi of FDG were injected, followed 40 min later by a
20-min image acquisition.
A high resolution PET scanner (ECAT 931/8; CTI/Siemens
Knoxville, TN) was used to acquire 15 transaxial images with
an interplane spacing of 6.5 mm. Images were reconstructed
with a Shepp filter (cutoff frequency: 3 cycles/pixel, effective
in-plane resolution: 11 mm [full width half maximum] FWHM)
and reoriented into short and long axis images. Visual inspec-
tion was used to classify myocardial segments according to
relative tracer uptake as follows: PET normal (normal uptake
of N-13 and F-18 activity), PET matched defect (concordantly
reduced uptake of both tracers) and PET mismatch (maintained
F-18 activity in segments with reduced N-13 activity). Analysis was
performed using the same 16-segment-model as for echocardiog-
raphy by investigators unaware of the echocardiographic and
histopathologic results. Viability was defined by either normal
perfusion or by presence of a perfusion-metabolism mismatch.
Tl-SPECT imaging. Thallium-201 single-photon emission
computed tomography (Tl-SPECT) imaging was performed in
a nonselected subgroup of seven patients (Tl-SPECT was not
available in the remaining patients for logistic reasons). All
patients underwent rest-redistribution Tl-SPECT imaging ac-
cording to a standardized clinical protocol. Several minutes
after the injection of 2–3 mCi thallium-201, rest imaging was
performed. Then, 3 to 4 h later the patient returned for
redistribution imaging.
Thallium images were obtained with a single-head large
field-of-view SPECT camera equipped with a low energy
all-purpose parallel hole collimator (Apex 415, APC-3, Elscint
Haifa) using a 20% window centered at 68 keV. Thirty
projection images were acquired by continuously rotating the
camera through a 180° arc starting from the 55° right anterior
oblique (RAO) position. Transaxial images were reconstructed
using a fifth-order butterworth filter with a cutoff frequency of
0.3 and were then reoriented into short and long axis images
Abbreviations and Acronyms
DE 5 dobutamine echocardiography
EF 5 ejection fraction
PET 5 positron emission tomography
Tl-SPECT 5 thallium-201 single-photon emission
computed tomography
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for image interpretation. The distribution of thallium was
visually assessed in 16 segments by experienced observers who
were unaware of the echocardiographic and histopathologic
results. The following score was used: 0 5 normal Tl-uptake,
1 5 mildly reduced uptake, 2 5 moderately reduced uptake,
3 5 severely reduced uptake, 4 5 no uptake. Viability was
defined as normal, mildly or moderately reduced Tl-uptake
(score #2) as visualized on the redistribution images.
Histopathology. At surgery, the native heart was excised
according to standard surgical technique. The left ventricle was
cut into a basal, mid- and apical third perpendicular to the left
ventricle’s long axis. After fixation with formalin for at least
12 h, each of the three slices was cut again to yield six cross
sections of the ventricles. Transmural tissue samples, 2–3 mm
thick, which included endocardium and epicardium, were cut
as large as possible for histologic examination. Samples were
taken to match each of the 16 segments according to the
segment model used by echocardiography. Trichrome staining
was used to facilitate identification of fibrous tissue.
Specimens of each segment were examined for gross and
histologic evidence of coagulation necrosis and fibrosis. In
cases where there was thinning of the ventricular wall, sections
were “normalized” to noninfarcted wall thickness, which along
with histologic evaluation was used to classify segments as
containing ,25%, 25–50%, 50–75%, or .75% viable myo-
cytes. For comparison, the following pathology score was used:
0 5 ,25% viable myocytes, 1 5 25–50%, 2 5 50–75%, 3 5
.75% viable myocytes.
Statistical analysis. Statistical analysis was performed on a
personal computer (Macintosh, Apple Computer) using a
commercial software package (JMP 3.0, SAS Institute). A p
value ,.05 was considered to indicate statistical significance.
Univariate one-way analysis of variance (ANOVA) was uti-
lized to characterize differences between segments classified
according to the results of diagnostic methods and pathology.
Multivariate ANOVA was used to study effects of differences
among patients together with effects of the segmental classifi-
cation.
Results
Patients underwent heart transplantation 2.8 6 1.9 months
after they had been studied. None had myocardial infarction or
episodes of unstable angina in the time between tests and
surgery. For logistic reasons, PET and Tl-SPECT imaging
could be performed in subgroups of only five and seven
patients of the total cohort.
Dobutamine echocardiography. One-hundred-eighty-eight
segments could be analyzed by echocardiography. Wall-motion
abnormalities at rest were found in 164 segments (87%). Of
those, 71 (43%) improved after dobutamine (60 segments by
one grade and 11 by two grades). By predefined criteria,
echocardiography classified 54% of all segments to be viable.
Compared with histology, where 15 segments could not be
analyzed, echocardiography classified 78% of segments with
more than 75% viable myocytes (pathology score 3), 71% of
those with 50% to 75% (score 2), 15% of those with 25% to
50% (score 1), and 19% of those with less than 25% viable
myocytes (score 0) to be viable (Table 1, Fig. 1).
Dobutamine echocardiography distinguished best between
segments with more and with less than 50% viable myocytes.
Sensitivity and specificity for detection of segments with more
than 50% viable cells was 76% and 82%, respectively. For the
detection of segments with more than 25% viable myocytes it
was 66% and 81%, respectively (Table 2). Segments that
improved by two grades more frequently had a percentage of
viable myocytes .75% than did those improving by one grade
(87% vs. 74%) but this difference did not reach statistical
significance.
Dobutamine echocardiographic results as compared with
histology did not significantly differ for the patient subgroups
with additional PET or additional SPECT and the total patient
cohort.
PET imaging. Of 80 segments that could be analyzed by
PET, 37 (46%) presented with normal perfusion and normal
FDG uptake, 13 (16%) demonstrated a perfusion/metabolism
mismatch and 30 (38%) showed neither perfusion nor metab-
olism. Thus, 50 segments (63%) were classified to be viable.
Viability was detected in 89%, 50%, 60%, and 33% of the
segments found to have .75% (pathology score 3), 50–75%
(score 2), 25–50% (score 1) and ,25% viable myocytes (score
Table 1. Histopathology Versus Dobutamine Echocardiography,





.75% 78 89 87
50–75% 71 50 87
25–50% 15 60 82
,25% 19 33 38
Figure 1. Viable and nonviable segments as assessed by dobutamine
echocardiography (DE), PET and Tl imaging (SPECT) for the four
histologically classified groups. The total number of segments available
for each method and the number of segments for each histological
group are indicated. Black sectors represent the percentage of seg-
ments classified to be nonviable.
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0) by the pathologist (Table 1, Fig. 1; 15 segments could not be
analyzed by histology). Sensitivity and specificity for detection
of segments with .50% viable myocytes were 79% and 58%,
respectively. For the detection of segments with .25% it was
75% and 67% (Table 2).
Tl-SPECT imaging. Thallium SPECT imaging demon-
strated 85 (76%) segments to be viable, of which 42 (38% of
all) segments presented with normal perfusion, 16 (14%)
segments with mildly reduced and 27 (24%) segments with
moderately reduced uptake. Of those segments with .75%
(pathology score 3) and with 50–75% viable myocytes by
histology (score 2), 87% in each group were found to be viable
by SPECT. Eighty-two percent of those with 25–50% (score 1)
and 38% of those less than 25% viable myocytes (score 0) were
still classified to be viable (Table 1, Fig. 1). Mean thallium
score increased with decreasing percentage of viable myocytes
and was 1.05 and 1.00 for segments with .75% and 50–75%
viable myocytes, respectively. It increased to 1.46 and 2.67 for
segments with 25–50% and those with ,25% viable myocytes,
respectively. However, only the group of segments with less
than 25% viable myocytes had a thallium score significantly
different from the other three groups (p , .05), whereas scores
of these three groups did not differ significantly by statistical
analysis. Multivariate ANOVA showed significant effects of
both histology (p , 0.001; F 5 11.6) and patients (p , 0.01;
F 5 3.2).
Accordingly, pathology scores continuously increased with
increasing thallium uptake (mean pathology score for seg-
ments with normal uptake, 2.25; mildly reduced, 2.13; moder-
ately reduced, 1.81; severely reduced, 1.21; no uptake, 0.55;
ANOVA p , .0001), indicating that the thallium uptake
increased with the percentage of viable myocytes per segment.
Moreover, multivariate ANOVA demonstrated significant ef-
fects for the thallium score (p , 0.001; F 5 9.2) as well as for
patients (p , 0.001; F 5 6.3).
Sensitivity and specificity for detection of segments with
.50% viable myocytes were 87% and 49%, respectively. For
the detection of segments with .25% it was 86% and 63%,
respectively (Table 2).
Comparison among DE, PET and Tl-SPECT imaging.
Agreement between echocardiography and PET was found in
54 of 78 segments (69%); between echocardiography and
Tl-SPECT it was observed in 80 of 110 segments (73%).
Disagreement was rarely found when echocardiography classi-
fied segments to be viable. Of these, 80% and 93% were also
classified to be viable by PET and Tl-SPECT, respectively.
However, 44% and 53% of segments without dobutamine
response were still found to be viable by PET and Tl-SPECT
(Fig. 2). Discrepant segments without dobutamine response
yet viable by PET or Tl-SPECT presented with a greater
percentage of viable myocytes in histology than did those
classified in accordance by both methods to be nonviable
(mean pathology score 1.33 and 1.73 vs. 0.47 and 0.68, p , .08
and p , .05 for PET and Tl-SPECT, respectively) but also
presented with significantly less viable myocytes than did
segments classified in agreement to be viable (pathology score
2.50 and 2.36 for PET and Tl-SPECT, respectively; p , .05 for
both). Thus, a negative dobutamine response but positive
nuclear test defined a specific group of segments with an
intermediate percentage of viable myocytes (Fig. 3). Multivar-
Table 2. Sensitivity and Specificity of Dobutamine
Echocardiography, PET and Tl-SPECT for the Detection of
Segments With .50% and .25% Viable Myocytes
DE PET Tl-SPECT




Sensitivity 76 79 87
Specificity 82 58 49




Sensitivity 66 75 86
Specificity 81 67 63
Figure 2. Comparison of dobutamine echocardiography (ECHO) with
PET and Tl imaging (SPECT). Black sectors indicate the percentage
of segments with disagreement between echocardiography and nuclear
method.
Figure 3. Pathology score (mean 6 SEM) for combined results of
echocardiography and nuclear studies. Pathology score 0 5 ,25%
viable myocytes, 1 5 25–50%; 2 5 50–75%; 3 5 .75% viable
myocytes. DE2/Tl2 5 both dobutamine echo and Tl-SPECT judged
nonviable; DE2/Tl1 5 no dobutamine response but viability by
Tl-SPECT; DE1/Tl1 5 both dobutamine and Tl-SPECT judged
viable; DE2/PET2 5 both dobutamine echo and PET judged nonvi-
able; DE2/PET1 5 no dobutamine response but viability by PET;
DE1/PET1 5 both dobutamine and PET judged viable.
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iate ANOVA revealed significant effects of the segmental
classification by diagnostic methods (Tl-SPECT: p , 0.001;
F 5 25.3; PET: p , 0.001; F 5 25.4) and of patients
(Tl-SPECT: p , 0.001; F 5 5.4; PET: p , 0.01; F 5 4.8).
Discussion
Assessment of myocardial viability. Several noninvasive
approaches have been developed for the identification of
myocardial viability in regions with contractile dysfunction due
to coronary artery disease. The three most frequently proposed
methods are based on the identification of very different
physiologic markers: PET imaging assesses myocardial meta-
bolic activity, typically using F-18 fluorodeoxyglucose as a
marker of glucose utilization and N-13 ammonia for assess-
ment of perfusion; Tl-SPECT assesses myocardial perfusion
and membrane integrity; and dobutamine echocardiography
(DE) assesses myocardial contractile reserve.
Early studies using nuclear methods reported high sensitiv-
ity as well as specificity for the detection of asynergic myocar-
dial segments that improved after revascularization (8–12).
More recent studies that compared nuclear methods with DE
and with regional wall motion after revascularization con-
firmed the high sensitivity and high negative predictive accu-
racy of PET and Tl-SPECT imaging and in general found
dobutamine to be slightly less sensitive (13–19). However, a
considerable percentage of segments found to be viable by
Tl-SPECT imaging did not show contractile reserve by echo-
cardiography and did not improve after revascularization,
indicating a limited specificity and positive predictive accuracy
of this method (13,17,19,21–23). In these studies, DE was
found to be significantly more specific for predicting recovery
after revascularization. Only a few studies have compared PET
and DE. Although PET has been reported to be more specific
and to yield higher positive predictive accuracy than Tl-SPECT
by some authors (13), similarly to Tl imaging segments without
dobutamine response have also been found to be viable by
PET in a high percentage (20,24). Concordance between
echocardiography and nuclear studies was typically only found
in approximately 60–70%. While most of the segments that
responded to dobutamine were usually found to be viable by
nuclear methods, discrepancies were mainly observed in seg-
ments without contractile reserve: approximately 50% to 80%
of segments without dobutamine response have been reported
to be viable by PET and Tl imaging (17,19,22,24).
The present study is, to our knowledge, the first to compare
all three noninvasive methods with a complete segment by
segment histologic examination of explanted hearts. The re-
sults demonstrate that in asynergic segments elicitation of
contractile response by dobutamine stimulation requires at
least 50% of the myocytes to be viable. Approximately 80% of
such segments responded to dobutamine, as observed by
echocardiography; only few (approximately 15–20%) of seg-
ments with less than 50% viable myocytes improved wall
motion with dobutamine. Conversely, nuclear methods, using
standard criteria, identified viability in a relatively high per-
centage of segments with even less than 25% of viable myo-
cytes (approximately 30% to 40%). Combining DE with either
PET or Tl-SPECT allowed for stratification of asynergic
segments into three subsets (Fig. 3): 1) Segments found to be
viable by both DE and either of the scintigraphic techniques
had the highest percentage of viable myocytes on histopatho-
logic examination; 2) segments found to be nonviable by both
DE and a scintigraphic technique had the lowest percentage of
viable myocytes; 3) segments that were viable by scintigraphy
and had no contractile response with dobutamine had a
percentage of viable cells intermediate to subsets 1 and 2.
Thus, discrepancies among these methods appear to be pri-
marily caused by the fact that dobutamine-induced improve-
ment of mechanical function depends on a greater percentage
of viable myocytes than that required for demonstration of
perfusion, cell integrity or metabolism by Tl-SPECT and PET.
These results may explain why dobutamine has been reported
to be more specific for predicting functional recovery, while
nuclear methods can detect smaller amounts of viable myo-
cytes in asynergic myocardial regions. More importantly, these
results indicate that the combined use of echocardiography
and nuclear methods may enhance our understanding about
the degree of viability in a given segment and may offer
information above and beyond simplistic classification as either
viable or nonviable.
Comparison with previous studies. The present study ex-
amined patients with very severely reduced left ventricular
function who ultimately underwent heart transplantation. This
patient population may represent an extreme end of the
spectrum compared to patients who undergo testing for myo-
cardial viability in everyday clinical practice. However, several
reasons make it likely that the concepts confirmed by the
present study can indeed be expected to explain the results
found in other patient populations.
First, the relations between nuclear methods and echocar-
diography found in the present study are very similar to what
we (23–25) and others (17,19,20,22) have reported for patients
who were evaluated for revascularization. In accordance with
the present study, discrepancies were most frequently observed
in segments not viable by echo but viable by PET or Tl-SPECT
(17,19,20,22–25). Previous results were also similar regardless
whether stress-redistribution-reinjection or rest-redistribution
protocols were used for Tl studies (17–19,22,25).
Second, previous studies have demonstrated that the rela-
tion between nuclear methods and echocardiography are sim-
ilar for patient groups with severe or moderate left ventricular
dysfunction (17,19,22,25), although better agreement between
the methods has been reported for hypokinetic as compared to
akinetic segments (19).
Third, sensitivity and specificity for the detection of seg-
ments with more than 50% viable cells in the present study for
all three methods are within the range of what has previously
been reported for the prediction of functional recovery of
segments after revascularization (6,7,17,19,21,24). Thus, the
concept, that generally at least roughly 50% of a segment’s
myocytes have to be viable to allow functional recovery after
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revascularization but that less than 50% viable cells are
sufficient to result in positive nuclear tests may prove to be
valid in a clinical setting, as well.
Information on histopathologic correlations has so far been
scarce. In 1976 Bodenheimer et al. (27), using transmyocardial
needle biopsies in patients undergoing coronary bypass surgery
after nitroglycerin ventriculography, reported that segments
with less than 10% muscle loss responded to nitroglycerin,
while unimproved zones demonstrated significant fibrosis. In a
more recent study, Depre et al. (28) reported 24 6 13%
fibrosis (range 0–50%) in biopsies of myocardial regions with
postoperative wall-motion improvement after revasculariza-
tion, while segments without improvement had 49 6 20%
fibrosis. However, these results were based on a total of only
eight needle biopsies from regions without postoperative im-
provement, and included only a single biopsy with more than
60% fibrosis. The small size of the specimen obtainable by in
vivo needle biopsies and their potentially limited representa-
tion of very heterogenous tissue may prove to be additional
limitations.
Other explanations for the disagreement between echocar-
diography and nuclear methods. Other explanations for the
discordance between echocardiography and nuclear studies
and for the lower specificity of nuclear methods to predict
functional recovery after revascularization have recently been
proposed (26).
First, there is always a potential for anatomic misalignment
between nuclear studies and the echocardiogram. Because the
standard for functional recovery in most studies is the echo-
cardiographic determination of improved wall motion, this fact
has been suspected to favor echocardiography in previous
studies. However, the results of the present study, which
compared all three methods with histology, make it rather
unlikely that this fact has significantly distorted previous
results. Although anatomic misalignment between the respec-
tive imaging methods themselves and between imaging meth-
ods and pathology remains a problem and may explain some of
the scatter for all three methods in the present study, it does
not appear to explain the basic differences between the ob-
tained results.
Second, the generally applied criteria to define viability by
Tl imaging may be suboptimal. Several studies, including the
present one, have demonstrated that the magnitude of regional
thallium uptake is related to the likelihood that administration
of dobutamine will elicit a contractile response. Segments with
a higher level of thallium activity have a greater likelihood of
responding to dobutamine stimulation (19,21,26). Thus, better
agreement between echocardiography and Tl, as well as higher
specificity of Tl for the prediction of recovery after revascular-
ization, may be achievable by using quantitative criteria and
higher threshold levels of thallium activity (30).
Third, it has been speculated that the follow-up interval in
previous studies was too short and that contractile function
may return later than 1 to 3 months after revascularization in
some segments, particularly when cellular dedifferentiation at
the ultrastructural level has occurred (31,32). However, how
myocytes that are cell dedifferentiated would appear on PET
or Tl-SPECT studies, or how they would contract on DE
studies, is unknown. Although we cannot exclude that cellular
dedifferentiation may play a role for the observed discordance
between echocardiography and nuclear studies and for the
previously observed limited specificity of nuclear methods, the
present findings support the concept that the varying mixture
of scar and viable myocytes in a given segment is the main
mechanism. Even so-called transmural myocardial infarctions
rarely destroy all of the myocytes in a region of myocardium.
Virtually always some myocytes are spared, mostly in the
subepicardial region. Their number may be large enough to
allow identification by PET and Tl-SPECT, but may not suffice
to generate effective contraction, so that the affected segment
may not be judged viable by DE.
Study limitations. There are several limitations to the
present study. First, the problems of patient selection and of
anatomic misalignment between the different methods have
been discussed above.
The patient population consists only of males and is small.
However, the number of transplantations performed in most
institutions is limited, and whether and when an individual
patient will actually undergo transplantation can be difficult to
foresee. In addition, the availability of whole explanted hearts
is limited by the harvesting of valves for homografts.
As the exact time of transplantation could not be foreseen,
there was a time interval between the performance of the
noninvasive tests and the time hearts were explanted and
became available for histologic examination. Although in none
of the patients myocardial infarction or episodes of unstable
angina were documented during the time between imaging
studies and transplantation, changes in viability status could
conceivably have occurred in some segments. However, as the
noninvasive tests were always performed within a few days of
each other their results should have been affected similarly.
Furthermore, diffuse hypoperfusion may appear normal by
PET and Tl-SPECT imaging and may have led to erroneous
results.
Also, the limited number of patients who underwent nu-
clear testing precluded a complete statistical analysis that
would include not only the effects of patients and segmental
classification but would also investigate statistical interaction
between these grouping variables. A general linear model that
would account for these effects could not be calculated as the
number of available data points was insufficient. Although
multivariate ANOVA demonstrated patient effects, we never-
theless believe the findings based on the segmental analysis to
be important, as these reflect the influence of the specific state
of the myocardium and blood supply on nuclear and echocar-
diographic findings in a given segment.
Additionally, this study does not provide direct information
about the relationship between histology and recovery of
myocardial function after revascularization. The only way to
obtain complete histologic examination, however, is to study
explanted hearts. The alternative approach of performing
intraoperative needle biopsies provides only a very limited
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number of very small tissue samples that may not be represen-
tative of other segments or even of other regions within the
sampled segment.
Finally, the results of this study only apply to regional
assessment and cannot be extrapolated to conclusions on
recovery of global left ventricular function after revasculariza-
tion.
Clinical implications. Results of the present study suggest
that identification of myocardial viability and of contractile
response may not necessarily be one and the same. It appears
that a given segment has to contain at least approximately 50%
viable myocytes to allow demonstration of contractile reserve,
as evidenced by a positive dobutamine response. Comparison
of the results presented here with previously reported clinical
data make it likely that a similar percentage of viable myocytes
may be required to allow functional recovery after revascular-
ization and that functional recovery may be more accurately
predicted by methods directly evaluating contractile reserve,
such as DE.
However, scintigraphic methods that assess perfusion
and/or metabolism appear also to identify segments with less
than 50% or even less than 25% viable myocytes. Although
revascularization of these segments may not contribute to a
significant improvement of left ventricular systolic function, it
may well provide clinical benefits by attenuating ventricular
dilatation and remodeling, by reducing the risk of ventricular
arrhythmias and by reducing the risk of subsequent fatal
ischemic events.
Dobutamine echocardiography (DE) and scintigraphic
methods, therefore, may well provide complementary informa-
tion in the assessment of myocardial viability. Current nuclear
techniques appear to be highly sensitive for the detection of
myocardial viability in asynergic myocardium, and negative
tests make it highly unlikely that a significant number of viable
myocytes are present in a given segment. Conversely, DE
appears to be particularly useful for identifying segments with
a greater number of viable myocytes and may, thus, have
particular value for predicting recovery of systolic function
after revascularization.
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